Viracta Therapeutics, Inc.
NASDAQ:VIRX
0.1699 (USD) • At close January 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0.12 | 2.073 | 0.237 | 0.669 | 2.536 | 3.061 | 5.734 | 7.956 | 3.754 | 5 | 0.033 | 3.762 | 5.417 | 9.664 | 13.709 | 16.522 | 10.305 |
| Cost of Revenue
| 0.492 | 0.21 | 0.178 | 0.032 | 0 | -0.903 | 0.009 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10.305 |
| Gross Profit
| -0.492 | -0.21 | -0.178 | 0.088 | 2.073 | 1.14 | 0.66 | 2.536 | 3.061 | 5.734 | 7.956 | 3.754 | 5 | 0.033 | 3.762 | 5.417 | 9.664 | 13.709 | 16.522 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0.733 | 1 | 4.809 | 0.987 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Reseach & Development Expenses
| 33.369 | 26.262 | 23.861 | 13.467 | 15.412 | 14.615 | 21.54 | 22.881 | 23.701 | 27.665 | 28.891 | 29.185 | 22.563 | 14.434 | 13.247 | 26.285 | 36.06 | 35.616 | 36.166 | 23.616 |
| General & Administrative Expenses
| 17.324 | 24.327 | 15.437 | 5.348 | 3.194 | 2.144 | 13.548 | 16.115 | 18.662 | 23.112 | 10.838 | 9.175 | 8.303 | 7.005 | 7.748 | 11.524 | 13.57 | 12.255 | 8.283 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 9.946 | 9.179 | -0.009 | -0.011 | -0.027 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 17.324 | 24.327 | 15.437 | 5.348 | 9.949 | 11.323 | 13.539 | 16.104 | 18.635 | 23.112 | 10.838 | 9.175 | 8.303 | 7.005 | 7.748 | 11.524 | 13.57 | 12.255 | 8.283 | 5.181 |
| Other Expenses
| 0 | 1.392 | -13.5 | -0.034 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,915.316 | 1,915.316 | 5.783 | 1.563 | 0 | 0 | 0 |
| Operating Expenses
| 50.693 | 50.589 | 25.798 | 18.815 | 25.361 | 25.938 | 35.079 | 38.985 | 42.336 | 50.777 | 39.729 | 38.36 | 30.866 | 21.439 | 20.995 | 37.809 | 49.63 | 47.87 | 44.449 | 28.797 |
| Operating Income
| -50.693 | -50.589 | 62.502 | -18.815 | -23.288 | -25.71 | -34.419 | -36.46 | -39.302 | -41.283 | -31.681 | -42.096 | -19.841 | -24.587 | -40.225 | -37.014 | -38.551 | -30.76 | -26.825 | -20.663 |
| Operating Income Ratio
| 0 | 0 | 0 | -156.792 | -11.234 | -108.481 | -51.448 | -14.377 | -12.84 | -7.2 | -3.982 | -11.214 | -3.968 | -743.206 | -10.694 | -6.833 | -3.989 | -2.244 | -1.624 | -2.005 |
| Total Other Income Expenses Net
| -0.365 | 1.392 | -75.464 | -0.202 | -0.042 | -0.905 | -1.039 | -1.563 | 2.626 | 2.041 | -2.825 | -9.345 | 5.725 | -24,566.079 | -22.992 | 0.989 | -1.556 | 3.408 | 0.428 | 0.133 |
| Income Before Tax
| -51.058 | -49.197 | -114.762 | -19.017 | -23.33 | -26.615 | -35.458 | -38.023 | -36.676 | -43.002 | -34.598 | -43.951 | -20.141 | -24.587 | -63.238 | -37.186 | -40.107 | -30.753 | -26.815 | -20.53 |
| Income Before Tax Ratio
| 0 | 0 | 0 | -158.475 | -11.254 | -112.3 | -53.001 | -14.993 | -11.982 | -7.499 | -4.349 | -11.708 | -4.028 | -743.206 | -16.812 | -6.864 | -4.15 | -2.243 | -1.623 | -1.992 |
| Income Tax Expense
| 0 | 0.577 | 88.3 | 0.182 | 0.514 | 1.154 | 1.396 | 1.721 | 0.939 | 1.719 | 2.917 | 1.855 | 0.3 | -21,077.175 | 0.001 | 0.171 | 0.21 | 0.478 | 0.674 | 0 |
| Net Income
| -51.058 | -49.774 | -203.062 | -19.199 | -23.33 | -26.615 | -35.458 | -38.023 | -36.676 | -44.721 | -37.515 | -45.806 | -20.441 | -24.587 | -63.239 | -37.357 | -40.317 | -31.23 | -27.489 | -20.53 |
| Net Income Ratio
| 0 | 0 | 0 | -159.992 | -11.254 | -112.3 | -53.001 | -14.993 | -11.982 | -7.799 | -4.715 | -12.202 | -4.088 | -743.206 | -16.812 | -6.896 | -4.172 | -2.278 | -1.664 | -1.992 |
| EPS
| -1.32 | -1.32 | -6.37 | -206.93 | -9.37 | -26.18 | -50.62 | -84.83 | -105.6 | -44.68 | -43.08 | -57.08 | -26.43 | -59.34 | -662.05 | -391.09 | -448.8 | -405.03 | -430.85 | -1,205.67 |
| EPS Diluted
| -1.32 | -1.32 | -6.37 | -206.93 | -9.37 | -26.18 | -50.62 | -84.83 | -105.6 | -43.62 | -43.08 | -57.08 | -26.43 | -59.34 | -662.05 | -391.09 | -448.8 | -405.03 | -430.85 | -1,205.67 |
| EBITDA
| -46.862 | -48.41 | -114.093 | -18.769 | -22.816 | -25.452 | -34.053 | -36.291 | -35.71 | -41.254 | -31.661 | -42.065 | -20.085 | -24.437 | -39.883 | -35.91 | -36.822 | -29.177 | -25.141 | -17.973 |
| EBITDA Ratio
| 0 | 0 | 0 | -156.408 | -5.815 | -108.443 | -51.435 | -14.373 | -12.831 | -7.195 | -3.98 | -11.205 | -3.957 | -738.665 | -10.603 | -6.629 | -3.81 | -2.128 | -1.522 | -1.744 |